Friday, May 1, 2026

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

Tesla’s Rough Patch: Profit and Revenue Expected to Fall

Ahead of Tesla's earnings announcement on the...

Tag: drills

No posts to display

Top News

- Our Sponsors Ad -

Follow us